| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 6+ ヶ月 |
| 被験者数 | 50 |
| 性別 | 女性 |
| 年齢 | 18-29, 30-44 |
| 体型 | 肥満 |
Supplementation of myo-inositol by itself at 2g daily for a period of six months in women with PCOS was associated with improvements in diastolic blood pressure. The combination with D-chiroinositol was the same at a lower dose (550mg and 13.8mg, respectively) when measured at six months, but seemed to act faster as inositol at 2g required six months to be fully effective.
Effects Of D-chiro-inositol In Lean Women With The Polycystic Ovary Syndrome
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 20 |
| 性別 | 女性 |
| 年齢 | 18-29, 30-44 |
| 体型 | 平均 |
6-8 weeks of supplementation with 600mg D-chiro-inositol daily in women with PCOS who also had an average BMI was able to increase ovulation secondary to reducing androgens, and appears to be effective in improving other biomarkers of health such as blood pressure and triglycerides.
Metabolic And Hormonal Effects Of Myo-inositol In Women With Polycystic Ovary Syndrome: A Double-blind Trial
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 42 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44 |
| 体型 | 肥満 |
Supplementation of 4,000mg inositol daily for a period of 12-16 weeks in women with PCOS was able to improve tolerance to glucose and glucose handling (as well as reduce the amount of insulin secreted in response to a meal) with minor benefits to cardiovascular health as well.
One-year Effects Of Myo-inositol Supplementation In Postmenopausal Women With Metabolic Syndrome
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 6+ ヶ月 |
| 被験者数 | 80 |
| 性別 | 女性 |
| 年齢 | 45-64, 65+ |
| 体型 | 肥満 |
Supplementation of myo-inositol at 2g twice daily for the course of one year in postmenopausal women with metabolic syndrome was associated with improvements on all metabolic parameters measured (cardiovascular health and glucose metabolism) although no influence on weight was noted.
Myo-inositol Treatment Increases Serum Plasmalogens And Decreases Small Dense LDL, Particularly In Hyperlipidemic Subjects With Metabolic Syndrome
| 効果 | なし |
| 試験方法 | コホート法 |
| 試験期間 | 1-2 週間 |
| 被験者数 | 17 |
| 性別 | 男女 |
| 年齢 | 30-44, 45-64 |
| 体型 | 肥満 |
Two weeks supplementation of _myo_-inositol at 5g (first week) and 10g (second week) was able to increase circulating levels of choline plasmalogen, which is thought to be the reason behind a reduction in LDL-C. These changes were not present in persons without metabolic syndrome.
Myo-inositol Treatment Increases Serum Plasmalogens And Decreases Small Dense LDL, Particularly In Hyperlipidemic Subjects With Metabolic Syndrome
| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 1-2 週間 |
| 被験者数 | 17 |
| 性別 | 男女 |
| 年齢 | 30-44, 45-64 |
| 体型 | 肥満 |
スポンサーリンクTwo weeks supplementation of _myo_-inositol at 5g (first week) and 10g (second week) was able to increase circulating levels of choline plasmalogen, which is thought to be the reason behind a reduction in LDL-C. These changes were not present in persons without metabolic syndrome.